This inventor holds 1 USPTO granted patent. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovations of Peter Loser
Introduction
Peter Loser is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of gene therapy vectors. His work has implications for medical research and treatment.
Latest Patents
Peter Loser holds a patent for a liver-specific adenovirus expression vector. This innovation is crucial for targeted gene therapy applications, allowing for more effective treatments for liver-related diseases. He has 1 patent to his name.
Career Highlights
Loser is affiliated with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V., a prestigious research organization in Germany. His role there has allowed him to engage in cutting-edge research and development in the field of gene therapy.
Collaborations
Throughout his career, Peter Loser has collaborated with esteemed colleagues, including Volker Sandig and Michael Strauss. These partnerships have enhanced the scope and impact of his research.
Conclusion
Peter Loser is a prominent figure in the field of biotechnology, with a focus on innovative gene therapy solutions. His contributions continue to influence medical research and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile